Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public HealthAbortion Family Medicine and Primary Care: Open Access

Determining the Period Prevalence and Acuity of Emergency Department Visits Following Induced Abortion Mistakenly Identified as Spontaneous Abortion: An Analytic Observational Prospective Cohort Study

Additionally co-authored by Christopher Craver

Abstract

Background

Induced abortions via mifepristone and misoprostol (medical abortion) represented 63% of abortions in the United States in 2023. Women are consistently advised to conceal their recent abortion when visiting the Emergency Department (ED). Consequently, ED visits may be mistakenly attributed to a prior spontaneous abortion or miscarriage rather than induced abortion.

Objectives

We sought to determine the period prevalence trajectory of these miscodes from 2004-2015 to 2016-2021. In addition, for the period 2016-2021, we sought to determine if there were differences in the severity or acuity of these miscoded visits compared to correctly classified post-abortion visits.

Methods

We analyzed Centers for Medicare and Medicaid Services (CMS) Transformed Medicaid Statistical Information System Analytic Files (TAF) to identify 28,534 emergency department visits for all causes, and their level of acuity, following either a medical or surgical abortion within 30 days. For abortion related visits, we determined whether the visits were miscoded as a spontaneous abortion or were correctly coded.

Results

Between the two time periods, miscode period prevalence rates following medical abortion increased from 4.7% of total visits to 18.0%; and from 45.5% of abortion-related visits to 83.5%. Following surgical abortion, miscodes increased from 1.2% of all-cause visits to 7.7%; abortion-related miscodes increased from 26.8% to 73.9%. During the period 2016-2021, ED visits following medical abortion were more likely to be miscoded than visits following surgical abortion: for all-cause visits, OR 2.63, P<.001; for abortion-related visits, OR 1.79, P<.001. Miscoded ED visits had significantly higher acuity than correctly coded visits. For all-cause visits following medical abortion, OR 3.68, P<.001; for all-cause visits following surgical abortion, OR 3.39, P<.001. For abortion-related visits following medical abortion, OR 1.51, P=.006; for abortion-related visits following surgical abortion, OR 1.41, P=.03.

Discussion

Coincident with the increasing dominance of medical abortion, there is a concurrent increase in the misattribution of post-induced abortion ED visits to a spontaneous abortion. High levels of visit acuity suggest that these miscodes represent a serious risk factor. Further, these miscodes mask and statistically deflate post-abortion complication rates and undermine both the science and medical management necessary to address these issues, representing a threat to effective surveillance.

 

Read Press Release

Read Complete Article

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

A graphic showing an outline of Kentucky with the text KENTUCKY ABORTION STATISTICS centered over it, detailing 2022 abortion data.

Abortion Reporting: Kentucky (2025)

An outline of the state of Alabama with the text ALABAMA ABORTION STATISTICS centered over it, reflecting current abortion reporting.

Abortion Reporting: Alabama (2025)

Text reading Virginia Abortion Statistics, providing 2022 abortion data, centered over a light gray silhouette of the state of Virginia inside a white circle on a blue background.

Abortion Reporting: Virginia (2024)

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image